XBiotech Inc.
XBIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $120,321 | $121,268 | $106,842 | $334,383 |
| - Cash | $172,677 | $200,023 | $157,306 | $236,983 |
| + Debt | $10,250 | $0 | $0 | $0 |
| Enterprise Value | -$42,106 | -$78,755 | -$50,464 | $97,400 |
| Revenue | $0 | $0 | $4,010 | $18,394 |
| % Growth | – | -100% | -78.2% | – |
| Gross Profit | $0 | $0 | $3,359 | $12,574 |
| % Margin | – | – | 83.8% | 68.4% |
| EBITDA | -$36,011 | -$22,569 | -$31,876 | -$22,434 |
| % Margin | – | – | -794.9% | -122% |
| Net Income | -$38,531 | -$24,557 | -$32,900 | -$17,414 |
| % Margin | – | – | -820.4% | -94.7% |
| EPS Diluted | -1.26 | -0.81 | -1.08 | -0.58 |
| % Growth | -55.6% | 25% | -86.2% | – |
| Operating Cash Flow | -$30,963 | -$18,725 | -$14,824 | $69,445 |
| Capital Expenditures | -$1,304 | -$362 | -$585 | -$3,525 |
| Free Cash Flow | -$32,267 | -$19,087 | -$15,409 | $65,920 |